| The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options S Choudhary, K Sharma, O Silakari Microbial Pathogenesis, 104673, 2020 | 182 | 2020 |
| Success stories of natural product-based hybrid molecules for multi-factorial diseases S Choudhary, PK Singh, H Verma, H Singh, O Silakari European journal of medicinal chemistry 151, 62-97, 2018 | 81 | 2018 |
| Structural investigation on the selective COX-2 inhibitors mediated cardiotoxicity: A review M Arora, S Choudhary, PK Singh, B Sapra, O Silakari Life sciences 251, 117631, 2020 | 66 | 2020 |
| Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19 S Choudhary, O Silakari Virus research 289, 198146, 2020 | 44 | 2020 |
| Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it H Verma, M Singh Bahia, S Choudhary, P Kumar Singh, O Silakari Drug Metabolism Reviews 51 (2), 196-223, 2019 | 43 | 2019 |
| An exhaustive compilation on chemistry of triazolopyrimidine: A journey through decades PK Singh, S Choudhary, A Kashyap, H Verma, S Kapil, M Kumar, M Arora, ... Bioorganic chemistry 88, 102919, 2019 | 35 | 2019 |
| Key updates on the chemistry and biological roles of thiazine scaffold: a review S Choudhary, O Silakari, PK Singh Mini Reviews in Medicinal Chemistry 18 (17), 1452-1478, 2018 | 25 | 2018 |
| Addressing selectivity issues of aldose reductase 2 inhibitors for the management of diabetic complications M Kumar, S Choudhary, PK Singh, O Silakari Future Medicinal Chemistry 12 (14), 1327-1358, 2020 | 21 | 2020 |
| Benzimidazole based hybrids against complex diseases: A catalogue of the SAR profile S Choudhary, M Arora, H Verma, M Kumar, O Silakari European Journal of Pharmacology 899, 174027, 2021 | 20 | 2021 |
| Phytochemical screening, cytotoxicity and anti-inflammatory activities of the leaf extracts from Lawsonia inermis of Indian origin to explore their potential for medicinal uses A Manuja, N Rathore, S Choudhary, B Kumar Medicinal chemistry 17 (6), 576-586, 2021 | 18 | 2021 |
| Von Willebrand factor: A key glycoprotein involved in thrombo-inflammatory complications of COVID-19 S Choudhary, K Sharma, PK Singh Chemico-Biological Interactions 348, 109657, 2021 | 17 | 2021 |
| Molecular dynamics/quantum mechanics guided designing of natural products based prodrugs of Epalrestat B Vyas, S Choudhary, PK Singh, A Singh, M Singh, H Verma, H Singh, ... Journal of Molecular Structure 1171, 556-563, 2018 | 15 | 2018 |
| Role of genetic polymorphisms in drug-metabolizing enzyme-mediated toxicity and pharmacokinetic resistance to anti-cancer agents: a review on the pharmacogenomics aspect G Narendra, S Choudhary, B Raju, H Verma, O Silakari Clinical Pharmacokinetics 61 (11), 1495-1517, 2022 | 14 | 2022 |
| Chemotherapeutic approaches against Trypanosoma evansi: retrospective analysis, current status and future outlook N S Rathore, A Manuja, B Kumar Manuja, S Choudhary Current Topics in Medicinal Chemistry 16 (20), 2316-2327, 2016 | 13 | 2016 |
| Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review B Raju, S Choudhary, G Narendra, H Verma, O Silakari Drug Metabolism Reviews 53 (1), 45-75, 2021 | 11 | 2021 |
| Identification of 2‐benzoxazolinone derivatives as lead against molecular targets of diabetic complications B Vyas, S Choudhary, PK Singh, B Singh, R Bahadur, AK Malik, O Silakari Chemical Biology & Drug Design 92 (6), 1981-1987, 2018 | 11 | 2018 |
| hCES1 and hCES2 mediated activation of epalrestat-antioxidant mutual prodrugs: Unwinding the hydrolytic mechanism using in silico approaches S Choudhary, O Silakari Journal of Molecular Graphics and Modelling 91, 148-163, 2019 | 10 | 2019 |
| QM/MM analysis, synthesis and biological evaluation of epalrestat based mutual-prodrugs for diabetic neuropathy and nephropathy S Choudhary, M Kumar, O Silakari Bioorganic Chemistry 108, 104556, 2021 | 9 | 2021 |
| Search for non-acidic ALR2 inhibitors: evaluation of flavones as targeted agents for the management of diabetic complications B Vyas, S Choudhary, PK Singh, M Kumar, H Verma, M Singh, AK Malik, ... Bioorganic Chemistry 96, 103570, 2020 | 8 | 2020 |
| Pharmacophore-based designing of putative ROS-1 targeting agents for NSCLC D Pathak, S Choudhary, PK Singh, M Singh, N Chadha, O Silakari Molecular Diversity 25, 1091-1102, 2021 | 7 | 2021 |
